logo
Heston Blumenthal says weight-loss drugs craze is ruining Britain's restaurants - even though he takes them himself

Heston Blumenthal says weight-loss drugs craze is ruining Britain's restaurants - even though he takes them himself

Daily Mail​2 days ago
Celebrity chef Heston Blumenthal says weight-loss drugs are killing restaurants - despite taking them himself.
He said that people are going to want smaller portions because brands like Wegovy, Ozempic and Mounjaro stop appetite.
As a result, there has been a decline in desire for tasting menus at fine dining restaurants such as his three-Michelin-starred The Fat Duck.
Meanwhile, labour, ingredients and fuel costs have increased while diners' appetites are decreasing and so they are ordering less.
The chef admitted he is worried for the future of his industry and believes it will only get worse when the weight-loss drugs become more accessible in the form of over the counter patches or tablets.
His restaurant group has taken a hit as it reported post-tax losses in 2024 of £2.1 million, after a loss of £1.4 million in 2023.
However Blumenthal has been taking Wegovy to to combat the effects of his bipolar medication.
He was sectioned following an acute manic episode in 2023. The illness caused the father-of-three to suffer hallucinations that led him to see phantom guns and believe the television was talking to him.
He was eventually admitted to a psychiatric hospital for three weeks, where he was diagnosed with bipolar disorder.
But high doses of treatment has caused him rapid weight gain.
'I've put on so much weight, but it's starting to come off now,' he said. 'I've lost eight kilos,' he told Times Radio.
The bipolar medication has also caused 'brain fog', slurred speech and problems with balance.
It was his wife, entrepreneur Melanie Ceysson, who asked doctors to admit him for psychiatric treatment.
I was only until he was sectioned he knew he had bipolar and thought he had only been living with an ADHD diagnosis he got in 2017.
'I had no idea. No idea at all,' Blumenthal said. 'And upon reflection, I realised that some of my past behaviour has not been normal.'
He has previously spoken of having a lot of road rage as a teenager. He also recalled that upon starting The Fat Duck he was able to survive on very little sleep - and suspects this was another potential early warning sign of bipolar disorder.
The multi-award winning restauranteur said he still has suicidal thoughts, but they have lessened in intensity.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Study: Avoiding ultra-processed foods while dieting can double weight loss
Study: Avoiding ultra-processed foods while dieting can double weight loss

Daily Mail​

time3 minutes ago

  • Daily Mail​

Study: Avoiding ultra-processed foods while dieting can double weight loss

By Consuming a diet low in ultra-processed foods could help supercharge weight loss , promising research suggested today. Additive-laden foods such as crisps and sweets have been vilified for decades over their supposed risks, with dozens of studies linking them to type 2 diabetes , heart disease and cancer . Experts have even called for UPFs—typically anything edible that has more artificial ingredients than natural ones—to be slashed from diets. Now, British scientists who tracked dozens of adults have discovered those who ate a diet rich in minimally processed foods and avoided UPFs, lost twice as much weight as those who often consumed UPFs. Sticking to meals cooked from scratch could also help curb food cravings, they also found. However, diets high in UPFs had little impact on blood pressure, heart rate, liver function and cholesterol. 'But not all ultra-processed foods are inherently unhealthy based on their nutritional profile.' In the study, the researchers tracked 50 people who were already consuming diets packed with UPFs and split them into two groups. Half were given an eight-week diet plan comprising minimally processed foods, such as overnight oats and spaghetti bolognese, while the other half were given foods like breakfast oat bars or lasagne ready meals. After completing one diet, the groups then switched. Researchers matched the two diets nutritionally on levels of fat, saturated fat, protein, carbohydrates, salt and fibre using the Eatwell Guide, which outlines recommendations on how to eat a healthy, balanced diet. They found those on the minimally processed diet lost more weight (2.06 per cent) compared to the UPF diet (1.05 per cent loss). The UPF diet also did not result in significant fat loss, the researchers said. Dr Dicken added: 'Though a 2 per cent reduction may not seem very big, that is only over eight weeks and without people trying to actively reduce their intake. 'If we scaled these results up over the course of a year, we'd expect to see a 13 per cent weight reduction in men and a 9 per cent reduction in women on the minimally processed diet, but only a 4 per cent weight reduction in men and 5 per cent in women after the ultra-processed diet. 'Over time this would start to become a big difference.' Those on the trial were also asked to complete questionnaires on food cravings before and after starting the diets. Those eating minimally processed foods had less cravings and were able to resist them better, the study suggests. However, researchers also measured others markers like blood pressure, heart rate, liver function, glucose levels and cholesterol and found no significant negative impacts of the UPF diet. The Eatwell Guide recommends the average woman should consume around 2,000 calories a day, while an average man should consume 2,500. Both diet groups had a calorie deficit, meaning people were eating fewer calories than what they were burning, which helps with weight loss. However, the deficit was higher from minimally processed foods at around 230 calories a day, compared with 120 calories per day from UPFs. Professor Rachel Batterham, senior author of the study from the UCL centre for obesity research, said: 'Despite being widely promoted, less than 1 per cent of the UK population follows all of the recommendations in the Eatwell Guide, and most people stick to fewer than half. 'The best advice to people would be to stick as closely to nutritional guidelines as they can by moderating overall energy intake, limiting intake of salt, sugar and saturated fat, and prioritizing high-fibre foods such as fruits, vegetables, pulses and nuts. Tracy Parker, nutrition lead at the British Heart Foundation, also said: 'The way this study was designed means it is more reflective of real-world conditions than previous research on UPFs. 'The small size of the study is a limitation, and the fact that most participants were women limits how much we can generalize the findings to the general population. 'We also can't be certain how closely the diets were followed, as participants self-reported what they ate during the study. 'Larger, longer-term studies will be needed to see if the greater weight loss on the minimally processed diets seen here translates into bigger improvements in risk factors, including blood pressure and cholesterol and blood sugar levels, and a reduced risk of developing heart and circulatory diseases.

Wegovy maker Novo hit with investor class action over revenue forecast cut
Wegovy maker Novo hit with investor class action over revenue forecast cut

Reuters

time4 minutes ago

  • Reuters

Wegovy maker Novo hit with investor class action over revenue forecast cut

Aug 4 (Reuters) - Novo Nordisk ( opens new tab, maker of the weight-loss drug Wegovy, has been sued in U.S. court by investors claiming the Danish pharmaceutical giant misled them with optimistic growth forecasts and minimized competition risks in the obesity market. The proposed class action lawsuit, opens new tab was filed on Friday in the federal court in New Jersey following a sharp decline in the company's stock price. Investors knocked $70 billion off Novo Nordisk's market value on a single trading day last week. Novo last week in a statement said it was lowering its 2025 sales and operating profit outlook due to lower growth expectations in the second half in the United States for Wegovy in the obesity market and the drugmaker's Ozempic in the diabetes market. Novo said its updated sales outlook for Wegovy stemmed from the 'persistent' use of compounded versions of the drug, competition and what it described as slower-than-expected market expansion. A representative from Novo and an attorney for the plaintiff did not immediately respond to requests for comment on Monday about the investor lawsuit. The lawsuit was filed on behalf of potentially thousands of investors who purchased Novo's stock between May 7, 2025 and July 28. The tight supply of Wegovy in the United States in 2022 prompted U.S. regulators to temporarily allow the sale of cheaper, compounded versions of the drug, known chemically as semaglutide. The U.S. Food and Drug Administration in February removed Wegovy from the agency's shortage list. Novo in June said it was ending a partnership with telehealth company Hims & Hers that began in late April, citing Hims' alleged improper marketing and sales of Wegovy copies. Novo accused Hims of 'deceptive promotion and selling of illegitimate, knockoff versions of Wegovy that put patient safety at risk.' Hims CEO Andrew Dudum in a response accused Novo management of misleading the public and making anticompetitive demands. The case is Eric Barta v. Novo Nordisk et al, U.S. District Court, District of New Jersey, No. 2:25-cv-14045. For plaintiff: Adam Apton of Levi & Korsinsky For defendants: No appearances yet Read more: Novo Nordisk shares dip further as Wegovy gains nearly erased Hims & Hers hit with investor lawsuits after Novo ends Wegovy partnership Wegovy maker Novo faces fee demand after losing copycat drug lawsuit Ozempic copies restricted after US judge denies injunction

The foods that could be stopping you from losing weight
The foods that could be stopping you from losing weight

The Independent

time33 minutes ago

  • The Independent

The foods that could be stopping you from losing weight

A study led by experts at University College London (UCL) and University College London Hospitals NHS Foundation Trust (UCLH) found that avoiding ultra-processed foods (UPFs), like pre-packaged sandwiches and protein bars, can lead to significantly greater weight and fat loss. Participants on a minimally processed diet lost twice as much weight (2.06 per cent) compared to those on a UPF diet (1.05 per cent) over an eight-week period. The research indicated that individuals consuming minimally processed foods spontaneously ate fewer calories and experienced fewer food cravings. Experts noted that UPFs, being hyperpalatable, can lead to increased calorie intake and reduced satiety, affecting eating behaviour. The study advises choosing less processed options and cooking from scratch for improved body weight, composition, and overall health.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store